The average one-year price target for Dyadic International (NasdaqCM:DYAI) has been revised to $4.08 / share. This is a ...

Thank you. Good evening, and welcome everyone to Dyadic International, Inc.'s Q3 2025 conference call. On today's call, our ...

Dyadic International Inc. (($DYAI)) has held its Q3 earnings call. Read on for the main highlights of the call. In a recent earnings call, Dyadic ...

Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1650831&tp_key=0f89478e24. An archive of the webcast will be available within 24 hours after completion of ...

Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned ...

Dyadic International, Inc. announced that it will release its financial results for the first quarter of 2025 and hold a corporate update conference call on May 14, 2025, at 5:00 p.m. Eastern Time.

Dyadic’s management team welcomes the opportunity to connect with investors, analysts, and industry partners during the conferences. To request a meeting, please reach out to [email protected].

Dyadic International will present on its C1 platform at the 2025 World Vaccine Congress, focusing on avian influenza and preclinical research. Dyadic International, Inc., a biotechnology company ...

Dyadic is focusing on leveraging its microbial platform technologies for itself and its collaborators in a wide range of applications, including human and animal vaccines, therapeutics, food, ...

JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the ...

Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1705993&tp_key=2267a6328b. An archive of the webcast will be available within 24 hours after completion of ...

Good evening, and welcome to Dyadic International's Q3 2025 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, November 12, 2025. I would now like to ...